InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (8 ops.)
Insider track record
OtherDisclosed buys
1
Disclosed sells
8
T+90 hit rate
100%
T+90 mean return
+39.2%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Avalon Ventures XI, L.P.. Officer active across 1 company, notably Janux Therapeutics, Inc.. Aggregated, 16 disclosures have been logged. Split: 1 buy · 8 sells. Total volume traded: €53.1m. History available since 13 November 2023. The latest transaction was disclosed on 16 October 2024 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations16 total
60,179 shares@ US$49.695.2% of flowCommon StockSEC:0001415889-24-025436:0
49,497 shares@ US$46.783.9% of flowCommon StockSEC:0001415889-24-024119:0
11,319 shares@ US$46.130.9% of flowCommon StockSEC:0001415889-24-023337:0
108,365 shares@ US$42.007.7% of flowCommon StockSEC:0001415889-24-023153:0
20,991 shares@ US$42.001.5% of flowCommon StockSEC:0001415889-24-023153:1
110,644 shares@ US$42.007.9% of flowCommon StockSEC:0001415889-24-023153:2
994 shares@ US$17.000.0% of flowCommon StockSEC:0001415889-24-023153:3
414 shares@ US$10.730.0% of flowCommon StockSEC:0001415889-24-023153:4
414 shares@ US$13.220.0% of flowCommon StockSEC:0001415889-24-023153:5
277 shares@ US$39.800.0% of flowCommon StockSEC:0001415889-24-023153:6
2,182 shares@ US$42.330.2% of flowCommon StockSEC:0001415889-24-023153:7
677,279 shares@ US$54.7564.0% of flowCommon StockSEC:0001415889-24-015673:0
438,722 shares0Common StockSEC:0001415889-24-006428:0
849,854 shares@ US$5.878.8% of flowCommon StockSEC:0001209191-23-055083:0
Ideal exit: 9 Aug 2024 (T+270)
1,138,665 sharesCommon StockSEC:0001209191-21-041032:0
1,138,665 sharesCommon StockSEC:0001209191-21-041032
16 of 16 declarations
